These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26378245)

  • 1. CT-guided injection of a TRPV1 agonist around dorsal root ganglia decreases pain transmission in swine.
    Brown JD; Saeed M; Do L; Braz J; Basbaum AI; Iadarola MJ; Wilson DM; Dillon WP
    Sci Transl Med; 2015 Sep; 7(305):305ra145. PubMed ID: 26378245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia.
    Chen SR; Pan HL
    J Neurophysiol; 2006 May; 95(5):3086-96. PubMed ID: 16467418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ablation of rat TRPV1-expressing Adelta/C-fibers with resiniferatoxin: analysis of withdrawal behaviors, recovery of function and molecular correlates.
    Mitchell K; Bates BD; Keller JM; Lopez M; Scholl L; Navarro J; Madian N; Haspel G; Nemenov MI; Iadarola MJ
    Mol Pain; 2010 Dec; 6():94. PubMed ID: 21167052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perineural resiniferatoxin selectively inhibits inflammatory hyperalgesia.
    Neubert JK; Mannes AJ; Karai LJ; Jenkins AC; Zawatski L; Abu-Asab M; Iadarola MJ
    Mol Pain; 2008 Jan; 4():3. PubMed ID: 18199335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar and different effects of capsaicin and resiniferatoxin on substance P release and transient receptor potential vanilloid type 1 expression of cultured rat dorsal root ganglion neurons.
    Yang X; Gong H; Liu Z; Liu H; Wang H; Li Z
    Methods Find Exp Clin Pharmacol; 2010; 32(1):3-11. PubMed ID: 20383340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preservation of acute pain and efferent functions following intrathecal resiniferatoxin-induced analgesia in rats.
    Bishnoi M; Bosgraaf CA; Premkumar LS
    J Pain; 2011 Sep; 12(9):991-1003. PubMed ID: 21680254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of nerve growth factor in neuropathic pain inhibition produced by resiniferatoxin treatment in the dorsal root ganglia.
    Tender GC; Li YY; Cui JG
    Neurosurgery; 2013 Jul; 73(1):158-65; discussion 165-6. PubMed ID: 23615109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain-derived neurotrophic factor redistribution in the dorsal root ganglia correlates with neuropathic pain inhibition after resiniferatoxin treatment.
    Tender GC; Li YY; Cui JG
    Spine J; 2010 Aug; 10(8):715-20. PubMed ID: 20452292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The vanilloid agonist resiniferatoxin for interventional-based pain control.
    Iadarola MJ; Mannes AJ
    Curr Top Med Chem; 2011; 11(17):2171-9. PubMed ID: 21671877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone cancer increases transient receptor potential vanilloid subfamily 1 expression within distinct subpopulations of dorsal root ganglion neurons.
    Niiyama Y; Kawamata T; Yamamoto J; Omote K; Namiki A
    Neuroscience; 2007 Aug; 148(2):560-72. PubMed ID: 17656027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pungency of TRPV1 agonists is directly correlated with kinetics of receptor activation and lipophilicity.
    Ursu D; Knopp K; Beattie RE; Liu B; Sher E
    Eur J Pharmacol; 2010 Sep; 641(2-3):114-22. PubMed ID: 20576527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of transient receptor potential vanilloid 2-expressing primary afferents stimulates synaptic transmission in the deep dorsal horn of the rat spinal cord and elicits mechanical hyperalgesia.
    Petitjean H; Hugel S; Barthas F; Bohren Y; Barrot M; Yalcin I; Schlichter R
    Eur J Neurosci; 2014 Oct; 40(8):3189-201. PubMed ID: 25104469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective targeting of TRPV1 expressing sensory nerve terminals in the spinal cord for long lasting analgesia.
    Jeffry JA; Yu SQ; Sikand P; Parihar A; Evans MS; Premkumar LS
    PLoS One; 2009 Sep; 4(9):e7021. PubMed ID: 19753113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective ablation of TRPV1 by intrathecal injection of resiniferatoxin in rats increases renal sympathoexcitatory responses and salt sensitivity.
    Yu SQ; Ma S; Wang DH
    Hypertens Res; 2018 Sep; 41(9):679-690. PubMed ID: 30006640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of vanilloid receptor 1-expressing primary afferent neurons for pain control.
    Karai L; Brown DC; Mannes AJ; Connelly ST; Brown J; Gandal M; Wellisch OM; Neubert JK; Olah Z; Iadarola MJ
    J Clin Invest; 2004 May; 113(9):1344-52. PubMed ID: 15124026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of transient receptor potential vanilloid 1 (TRPV1) by resiniferatoxin.
    Raisinghani M; Pabbidi RM; Premkumar LS
    J Physiol; 2005 Sep; 567(Pt 3):771-86. PubMed ID: 16037081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged analgesic response of cornea to topical resiniferatoxin, a potent TRPV1 agonist.
    Bates BD; Mitchell K; Keller JM; Chan CC; Swaim WD; Yaskovich R; Mannes AJ; Iadarola MJ
    Pain; 2010 Jun; 149(3):522-528. PubMed ID: 20403666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vanilloid receptor 1-positive neurons mediate thermal hyperalgesia and tactile allodynia.
    Tender GC; Li YY; Cui JG
    Spine J; 2008; 8(2):351-8. PubMed ID: 18029293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRPV1, NK1 receptor and substance P immunoreactivity and gene expression in the rat lumbosacral spinal cord and urinary bladder after systemic, low dose vanilloid administration.
    Heng YJ; Saunders CI; Kunde DA; Geraghty DP
    Regul Pept; 2011 Apr; 167(2-3):250-8. PubMed ID: 21329730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pain control through selective chemo-axotomy of centrally projecting TRPV1+ sensory neurons.
    Sapio MR; Neubert JK; LaPaglia DM; Maric D; Keller JM; Raithel SJ; Rohrs EL; Anderson EM; Butman JA; Caudle RM; Brown DC; Heiss JD; Mannes AJ; Iadarola MJ
    J Clin Invest; 2018 Apr; 128(4):1657-1670. PubMed ID: 29408808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.